deCODE Genetics Announces Webcast of Presentation
News Feb 07, 2006
deCODE genetics has announced that its presentation at Nasdaq’s U.S. Small Cap Conference will be webcast live. deCODE CEO Dr. Kari Stefansson will provide an overview of the company’s drug development programs and business.
The presentation will be delivered at 10am GMT/5am EST on Wednesday, February 8, 2006, at the Merrill Lynch Financial Centre in London.
The webcast will be archived for at least one week on both sites. Those interested in listening should log on a few minutes in advance, in order to download any software or complete any sign-in that may be required.
GlaxoSmithKline plc (GSK) has launched a five-year, $67 million collaboration with the San Francisco and Berkeley campuses of the University of California to build a state-of-the-art laboratory. The goal is to use CRISPR technologies to explore how genes cause disease and to rapidly accelerate the discovery of new drugs.